Influence of promoter/enhancer region haplotypes on MGMT transcriptional regulation: A potential biomarker for human sensitivity to alkylating agents

Carcinogenesis

Volumn 35, Issue 3, 2014, Pages 564-571

  Xu, Meixiang ^a   Nekhayeva, Ilona ^a   Cross, Courtney E ^a   Rondelli, Catherine M ^a   Wickliffe, Jeffrey K ^b   Abdel Rahman, Sherif Z ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b TULANE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE;

ARTICLE; CANCER CELL; CONTROLLED STUDY; DATA BASE; DOWN REGULATION; DRUG SENSITIVITY; ENHANCER REGION; GENE FREQUENCY; GENETIC TRANSFECTION; GLIOBLASTOMA; HAPLOTYPE; HUMAN; HUMAN CELL; LUCIFERASE ASSAY; NORMAL HUMAN; PHYLOGENY; PRIORITY JOURNAL; PROMOTER REGION; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSCRIPTION REGULATION; UPREGULATION;

ALKYLATING AGENTS; BASE SEQUENCE; BIOLOGICAL MARKERS; DNA PRIMERS; ENHANCER ELEMENTS, GENETIC; GENE EXPRESSION REGULATION; HAPLOTYPES; HUMANS; O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE; PROMOTER REGIONS, GENETIC; TRANSCRIPTION, GENETIC;

EID: 84895831328     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgt355     Document Type: Article

References (47)

1. Koike,G. et al. (1990) Purification, structure, and biochemical properties of human O6-methylguanine-DNA methyltransferase. J. Biol. Chem., 265, 14754-14762.
2. Becker,R.A. et al. (1985) Repair of O4-methyldeoxythymidine residues in DNA by mammalian liver extracts. Carcinogenesis, 6, 313-317.
3. Pegg,A.E. (2000) Repair of O(6)-alkylguanine by alkyltransferases. Mutat. Res., 462, 83-100.
4. Daniels,D.S. et al. (2004) DNA binding and nucleotide flipping by the human DNA repair protein AGT. Nat. Struct. Mol. Biol., 11, 714-720.
5. Liu,L. et al. (1999) Reduced lung tumorigenesis in human methylguanine DNA-methyltransferase transgenic mice achieved by expression of transgene within the target cell. Carcinogenesis, 20, 279-284.
6. Pegg,A.E. (1990) Mammalian O6-alkylguanine-DNA alkyltransferase: regulation and importance in response to alkylating carcinogenic and therapeutic agents. Cancer Res., 50, 6119-6129.
7. Jackson,P.E. et al. (1996) Frequency of Ki-ras mutations and DNA alkylation in colorectal tissue from individuals living in Manchester. Mol. Carcinog., 16, 12-19.
8. Dumenco,L.L. et al. (1993) The prevention of thymic lymphomas in transgenic mice by human O6-alkylguanine-DNA alkyltransferase. Science, 259, 219-222.
9. Gerson,S.L. et al. (1994) Alkyltransferase transgenic mice: probes of chemical carcinogenesis. Mutat. Res., 307, 541-555.
10. Gerson,S.L. (2002) Clinical relevance of MGMT in the treatment of cancer. J. Clin. Oncol., 20, 2388-2399.
11. Gerson,S.L. (2004) MGMT: its role in cancer aetiology and cancer therapeutics. Nat. Rev. Cancer, 4, 296-307.
12. Margison,G.P. et al. (2002) Mechanisms of carcinogenicity/chemotherapy by O6-methylguanine. Mutagenesis, 17, 483-487.
13. Margison,G.P. et al. (2003) Variability and regulation of O6-alkylguanine- DNA alkyltransferase. Carcinogenesis, 24, 625-635.
14. Silber,J.R. et al. (2012) O(6)-methylguanine-DNA methyltransferase in glioma therapy: promise and problems. Biochim. Biophys. Acta, 1826, 71-82.
15. Kaina,B. et al. (2007) MGMT: key node in the battle against genotoxicity, carcinogenicity and apoptosis induced by alkylating agents. DNA Repair (Amst), 6, 1079-1099.
16. Harris,L.C. et al. (1991) Characterization of the promoter region of the human O6-methylguanine-DNA methyltransferase gene. Nucleic Acids Res., 19, 6163-6167.
17. Pegg,A.E. et al. (2007) Human variants of O6-alkylguanine-DNA alkyltransferase. DNA Repair (Amst), 6, 1071-1078.
18. Bhakat,K.K. et al. (2003) CpG methylation-dependent repression of the human O6-methylguanine-DNA methyltransferase gene linked to chromatin structure alteration. Carcinogenesis, 24, 1337-1345.
19. Danam,R.P. et al. (2005) Epigenetic regulation of O6-methylguanine-DNA methyltransferase gene expression by histone acetylation and methyl-CpG binding proteins. Mol. Cancer Ther., 4, 61-69.
20. Krzesniak,M. et al. (2004) Polymorphisms in TDG and MGMT genes- epidemiological and functional study in lung cancer patients from Poland. Ann. Hum. Genet., 68(Pt 4), 300-312.
21. Ogino,S. et al. (2007) MGMT germline polymorphism is associated with somatic MGMT promoter methylation and gene silencing in colorectal cancer. Carcinogenesis, 28, 1985-1990.
22. Leng,S. et al. (2011) The A/G allele of rs16906252 predicts for MGMT methylation and is selectively silenced in premalignant lesions from smokers and in lung adenocarcinomas. Clin. Cancer Res., 17, 2014-2023.
23. McDonald,K.L. et al. (2013) The T genotype of the MGMT C>T (rs16906252) enhancer single-nucleotide polymorphism (SNP) is associated with promoter methylation and longer survival in glioblastoma patients. Eur. J. Cancer, 49, 360-368.
24. Hawkins,N.J. et al. (2009) MGMT methylation is associated primarily with the germline C
25. Candiloro,I.L. et al. (2009) Detection of MGMT promoter methylation in normal individuals is strongly associated with the T allele of the rs16906252 MGMT promoter single nucleotide polymorphism. Cancer Prev. Res. (Phila), 2, 862-867.
26. Kristensen,L.S. et al. (2011) Methylation of MGMT in malignant pleural mesothelioma occurs in a subset of patients and is associated with the T allele of the rs16906252 MGMT promoter SNP. Lung Cancer, 71, 130-136.
27. Chae,M.H. et al. (2006) O6-alkylguanine-DNA alkyltransferase gene polymorphisms and the risk of primary lung cancer. Mol. Carcinog., 45, 239-249.
28. Hu,Z. et al. (2007) Genetic variants in MGMT and risk of lung cancer in Southeastern Chinese: a haplotype-based analysis. Hum. Mutat., 28, 431-440.
29. Wang,L. et al. (2006) Association of genetic variants of O6-methylguanine- DNA methyltransferase with risk of lung cancer in non-Hispanic Whites. Cancer Epidemiol. Biomarkers Prev., 15, 2364-2369.
30. Park,J.H. et al. (2010) MGMT -535G
31. Zawlik,I. et al. (2009) Promoter methylation and polymorphisms of the MGMT gene in glioblastomas: a population-based study. Neuroepidemiology, 32, 21-29.
32. Felsberg,J. et al. (2009) Prognostic significance of molecular markers and extent of resection in primary glioblastoma patients. Clin. Cancer Res., 15, 6683-6693.
33. Zhang,Z. et al. (2010) Polymorphisms of the DNA repair gene MGMT and risk and progression of head and neck cancer. DNA Repair (Amst), 9, 558-566.
34. Gabriel,S.B. et al. (2002) The structure of haplotype blocks in the human genome. Science, 296, 2225-2229.
35. Schug,J. et al. (1997) Modeling transcription factor binding sites with Gibbs Sampling and Minimum Description Length encoding. Proc. Int. Conf. Intell. Syst. Mol. Biol., 5, 268-271.
36. Schug,J. et al. (1997) TESS, Transcription Element Search Software on the WWW (Technical report CBIL-TR-1997-1001-v0.0). Computational Biology and Informatics Laboratory, School of Medicine, University of Pennsylvania. http://www.cbil.upenn.edu/tess
37. Ding,K. et al. (2003) LDA-a java-based linkage disequilibrium analyzer. Bioinformatics, 19, 2147-2148.
38. Egyházi,S. et al. (2002) Novel O6-methylguanine-DNA methyltransferase SNPs: a frequency comparison of patients with familial melanoma and healthy individuals in Sweden. Hum. Mutat., 20, 408-409.
39. Rusin,M. et al. (1999) Novel genetic polymorphisms in DNA repair genes: O(6)-methylguanine-DNA methyltransferase (MGMT) and N-methylpurine-DNA glycosylase (MPG) in lung cancer patients from Poland. Hum. Mutat., 14, 269-270.
40. Harris,L.C. et al. (1994) Identification of a 59 bp enhancer located at the first exon/intron boundary of the human O6-methylguanine DNA methyltransferase gene. Nucleic Acids Res., 22, 4614-4619.
41. Boldogh,I. et al. (1998) Regulation of expression of the DNA repair gene O6-methylguanine-DNA methyltransferase via protein kinase C-mediated signaling. Cancer Res., 58, 3950-3956.
42. Heimberger,A.B. et al. (2005) Loss of the AP-2alpha transcription factor is associated with the grade of human gliomas. Clin. Cancer Res., 11, 267-272.
43. Biswas,T. et al. (1999) Activation of human O6-methylguanine-DNA methyltransferase gene by glucocorticoid hormone. Oncogene, 18, 525-532.
44. Grombacher,T. et al. (1996) Induction of the alkyltransferase (MGMT) gene by DNA damaging agents and the glucocorticoid dexamethasone and comparison with the response of base excision repair genes. Carcinogenesis, 17, 2329-2336.
45. Bady,P. et al. (2012) MGMT methylation analysis of glioblastoma on the Infinium methylation BeadChip identifies two distinct CpG regions associated with gene silencing and outcome, yielding a prediction model for comparisons across datasets, tumor grades, and CIMP-status. Acta Neuropathol., 124, 547-560.
46. Malley,D.S. et al. (2011) A distinct region of the MGMT CpG island critical for transcriptional regulation is preferentially methylated in glioblastoma cells and xenografts. Acta Neuropathol., 121, 651-661.
47. Lienert,F. et al. (2011) Identification of genetic elements that autonomously determine DNA methylation states. Nat. Genet., 43, 1091-1097.